
Bioporto A/S
CSE:BIOPOR

Intrinsic Value
The intrinsic value of one
BIOPOR
stock under the Base Case scenario is
1.299
DKK.
Compared to the current market price of 1.466 DKK,
Bioporto A/S
is
Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Bioporto A/S
Fundamental Analysis


Revenue & Expenses Breakdown
Bioporto A/S
Balance Sheet Decomposition
Bioporto A/S
Current Assets | 100m |
Cash & Short-Term Investments | 76.3m |
Receivables | 15.5m |
Other Current Assets | 8.1m |
Non-Current Assets | 8.9m |
Long-Term Investments | 2.1m |
PP&E | 551k |
Intangibles | 311k |
Other Non-Current Assets | 5.9m |
Free Cash Flow Analysis
Bioporto A/S
DKK | |
Free Cash Flow | DKK |
Earnings Waterfall
Bioporto A/S
Revenue
|
34.9m
DKK
|
Cost of Revenue
|
-10.3m
DKK
|
Gross Profit
|
24.6m
DKK
|
Operating Expenses
|
-93.7m
DKK
|
Operating Income
|
-69.1m
DKK
|
Other Expenses
|
7.8m
DKK
|
Net Income
|
-61.3m
DKK
|
BIOPOR Profitability Score
Profitability Due Diligence
Bioporto A/S's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Score
Bioporto A/S's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
BIOPOR Solvency Score
Solvency Due Diligence
Bioporto A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Score
Bioporto A/S's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOPOR Price Targets Summary
Bioporto A/S
According to Wall Street analysts, the average 1-year price target for
BIOPOR
is 3.06 DKK
with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.
Dividends
Current shareholder yield for BIOPOR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BIOPOR
stock under the Base Case scenario is
1.299
DKK.
Compared to the current market price of 1.466 DKK,
Bioporto A/S
is
Overvalued by 11%.